In HIV/AIDS Fight, Tough Choices Loom For Thailand

Law360, New York (August 16, 2006, 12:00 AM EDT) -- Weeks after protestors rallied against British drug maker GlaxoSmithKline’s efforts to patent an anti-retroviral in Thailand, the World Bank warned in a report Wednesday that the country must decide whether to shell out market prices for patented drugs as a rising number of Thais living with HIV/AIDS are forced to turn to so-called second-line drugs.

The report, “The Economics of Effective AIDS Treatment: Evaluating Policy Options for Thailand,” praised Thailand's drug provision program, the National Access to Antiretroviral Program for People Living with HIV/AIDS (NAPHA), which...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.